We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Scientists have developed an innovative nanocarrier that can selectively target and deliver a chemotherapy payload to cancer cells without adverse effects on healthy cells.
University of Salford researchers have uncovered ways that energetic cancer stem cells (e-CSCs) are responsible for cell growth, and consequently have identified new therapeutic targets.....
Scottish biotech TC BioPharm (TCB) has won European Union funding to develop a new “off-the-shelf” cell therapy for several types of solid tumour cancers.
Aids R&D initiatives to advance precision medicine. AMSBIO has introduced a new range of cancer cell line models and culture media for the most difficult to culture tumour types where no models may exist.